REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $913,329 | -25.5% | 32,996 | -28.0% | 0.00% | -50.0% |
| Q2 2023 | $1,225,926 | +23.5% | 45,829 | 0.0% | 0.01% | +200.0% |
| Q1 2023 | $992,656 | -26.6% | 45,829 | -19.3% | 0.00% | -33.3% |
| Q4 2022 | $1,352,309 | +20.7% | 56,772 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,120,000 | -26.3% | 56,772 | -27.2% | 0.00% | -25.0% |
| Q2 2022 | $1,519,000 | -39.9% | 77,931 | -21.4% | 0.00% | -20.0% |
| Q1 2022 | $2,528,000 | +1.4% | 99,104 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $2,494,000 | -8.5% | 99,104 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $2,726,000 | -17.2% | 99,104 | -4.4% | 0.01% | -22.2% |
| Q2 2021 | $3,292,000 | -30.8% | 103,702 | 0.0% | 0.01% | -40.0% |
| Q1 2021 | $4,758,000 | +10.1% | 103,702 | -5.0% | 0.02% | +7.1% |
| Q4 2020 | $4,322,000 | -7.2% | 109,179 | -18.4% | 0.01% | -22.2% |
| Q3 2020 | $4,655,000 | – | 133,776 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |